text:
Iranian Socialists Propose Unity
Read online at https://workersliberty.org/node/7960
Submitted by cathy n on 31 May, 1995 - 3:25
Representatives of nine political and regional groups who attended a meeting of 'Etehad Chap Kargari' (Workers' Left Unity) passed the following resolution on the 12 February 1995 in Germany:
The crisis engulfing the Iranian communist movement with its specific characteristics within the framework of an international crisis, has halted the formation and organisation of a genuinely radical socialist alternative in Iran. The objective in forming Workers' Left Unity (WLU) is to create the conditions that will help the formation and development of such a tendency and to pave the way for our joint efforts in the creation of a revolutionary party and to facilitate our future participation in any mobilisation of the working class. This political alliance believes in:
* the necessity for the overthrow of the capitalist Islamic Republic in Iran and the formation of a workers' state relying on the self-governing organs of workers and toilers.
* socialism as a force capable of expanding democracy in all political, social and economic spheres, abolition of exploitation, establishment of social ownership relying on the self-rule of producers and abolition of social classes.
* the inseparable characteristics of democracy and socialism and defence of all unconditional political freedoms, defending the right to universal voting, defending pluralism for all social strata.
* the struggle to organise workers on the basis of their class interests and on the basis of the confrontation between capital and labour. To help the independent mobilisation of the working class in economic, social, political and cultural issues.
* the struggle against patriarchy and male chauvinism, racial discrimination and the battle to eradicate cultural, national, religious, sexual bias which are an integral part of the struggle for socialism.
* internationalism and adherence to its principles.
Although the above are sufficient to distinguish this alliance from other opposition forces claiming to support socialism, on their own they are inadequate for unification within a single political party. This alliance will follow a process of development and following a period of debate, discussion and practical co-operation, encouraging other ideological tendencies it will be able to clarify its positions further and pave the way for the formation of a single party within which the right to form factions and tendencies will be respected. Those participating in this alliance do not consider themselves as the only forces of this alliance and invite all groups and individuals who agree with the above points to join them maintaining their organisational/political independence. Such forces can form local independent, permanent branches which will form the base of this alliance. Such branches will expand the discussion on issues concerning the way out of the present crisis, tactical programmes and strategic issues necessary for creating the revolutionary party capable of leading the workers' socialist revolution, seeking further alliances in the democratic and socialist arena.
l Etehad Kargarn Enghelabi Iran (Rahe Kargar) — Revolutionary Workers'
l Alliance Iran (Workers Path) l Hezb Ranjbaran — Toilers Party of Iran
l Daftarhaye Kargari — Socialist Workers' Socialist Bulletin l Sazman Kargaran Enghelabi Iran (Rahe Kargar) — Organisation of Revolutionary Workers of Iran (Workers Path) l Hasten Agahaliat — Minority Group l Faalan Sazman Cherikhaye Fedayii Khalgh Iran — Activists of the Organisation of Iranian Peoples' Fedayin Guerrillas (abroad)
l Hamkaran Projet Ijad Bulletin Bahshe socialisthayeh Enghelabi — The project for revolutionary socialist debate l Some of the cadres from Fedayin Minority l Independent activists of the left
VIDEO: Workers' struggles and political prisoners in Iran
Session on Iran at IFF19.
Pitfalls of knee-jerk "blame Israel"
If there was evidence of Israel's involvement in attacks on tankers in the Gulf, then that...
Behind the US-Iran tension
The economic pressure on the Iranian regime is constantly rising and the level of mass...
US and Iran in stand-off
The US is applying pressure to get the Iranian regime to give more concessions.
May Day arrests in Iran
Workers, teachers, students and pensioners demonstrated outside the Iranian regime's...
Workers' Liberty 21, May 1995Iran


Hiring a Brentwood Moving Company should be one of the easiest choices that you can make. Instead of getting stressed over the packing, unpacking, assembly, and disassembly process, you should feel totally comfortable and safe with your movers in Brentwood. The process doesn't have to be a difficult one, and we're here to let you know that we offer a plethora of personalized services that you can take advantage of to get the kind of move that you want. Our Brentwood Movers make even the most complex moves simple—so give us a call and let us know how we can help!
Too often unpacking, packing, transport, and assembly and disassembly of furniture is a process that people go alone. That simply doesn't have to be the case. Instead of working hard on your own, why not work with a company that is dedicated to the success of your move? We work hard to follow your instructions and make your move as worry-free as possible. Our Brentwood movers are prepared to help you get exactly what you want out of the process, and no matter how complex the move might be, you can rest assured that we've seen more difficult.
Making sure that your Brentwood movers are licensed and insured is extremely important. If you do not have an insured moving company, you can be held liable for mistakes or damage that occurs during the unpacking, packing, assembly, and disassembly process. The liability for damages to the building or to your own items can be substantial, so it is important to recognize just how vital insurance can be. Don't put yourself at risk. Instead, you should choose Brentwood movers that offer you a variety of different insurance choices. Our Los Angeles based moving company provides certificates of insurance which are frequently required by high-end luxury apartment buildings in Wilshire Corridor.
We're ready to help you with move and take all of the pressure off of you. Give us a call today and we'll let you know how our Brentwood movers can help you with the assembly, disassembly, packing, and unpacking portions of your move. We also offer a plethora of other services, including storage. This way, you can keep your belongings safe and protected during the entire transport process. We're willing to personalize the entire experience so that you get the most out of your move. Make your next move on your terms. We are proud to demonstrate our impeccable online reviews around the web – Please check us on Yelp! Contact us today and let us start helping you!


Feast At Home With Online Food Orders In Delhi | My Favorite Restaurants for Food Home Delivery | The Shopaholic Diaries - Indian Fashion, Shopping and Lifestyle Blog !
Today I am going to write about my second love after Fashion & Shopping as mentioned in the title - Food. Well, if you follow me on Instagram or Zomato, it's not hidden from anyone that I am a foodie and love trying new cuisines very often.
As I live away from home and rarely cook myself, I mostly order order food online in Delhi and it also serves as a saviour for me. With so many online food order websites, the task of ordering your favorite cuisine online and getting it delivered at your doorsteps has become really easy.
Pizza Hut : Talking about Food Home Delivery in Delhi, how can I ever miss Pizza Hut and their amazing range of pizzas and appetizers. Have you tried their new range called Flavors of The World in which they feature wide range of toppings from all around the world? I recently tried their El Mexicano Nacho Pizza and it tastes real good, much better than all their previous pizzas. Though talking about their general range of pizzas, Country Feast pizza has been my all time favorite.
Domino's Pizza : So basically I choose Domino's over Pizza Hut to order Pizza online in Delhi only when they are having a 1+1 offer or whenever I am ordering pizza at work where all my colleagues prefer Domino's. Still I do like their Garlic Bread which I don't think any other pizza restaurant does well. Their new Subwich is also worth trying which has a delicious patty between freshly baked crusts.
August Spice : It is my go-to restaurant whenever my friends are visiting my place or whenever I am craving North Indian food. Their Kebabs and Chinese starters are to die for, and I totally love their Veg curry dishes, especially Paneer Butter Masala.
The best part of ordering food online is that you can easily find the Contact details of a particular restaurant from various online directories and place an order online or through a call easily and fuss-free. There are also various options available to make the payment - Cash on delivery, Net Banking or through Credit/Debit card - making it easier at times when you are running short of cash and don't feel like rushing to the ATM to pay the delivery guy.
I have had a very pleasant experience placing online food orders with these restaurants and always rely on them whenever I wish to get home food delivery.
Which is your favorite restaurant when it comes to getting food delivered at home? Do let me know in the Comments below.
To find more offers on online food delivery check out tinyowl offers at Grabon India.
there is another online website through which you can order delicious foods...visit Tinyowl and also avail the coupons at couponchaska.


text:
We actively engage governments, regulators and legislators on issues of concern as well as provide expertise to support public policy development in key areas – from supporting diversity to progressing decarbonisation.?
Policy priorities for a clean energy future
As we expand activities across Europe, and as Europe's long-term climate strategy is being defined, we have developed policy priorities for a cleaner energy system focused on:
maximising renewables;
embracing clean and connected mobility;
investing in flexibility and energy efficiency; and
building the smart energy infrastructure of the future
Statutory carers leave
Centrica and Carers UK are calling on the UK Government to introduce 5-10 days of mandatory paid carers leave for all employers. Iain Conn, Group Chief Executive of Centrica, has written to the chief executives of the UK's 100 largest employers to encourage more support for carers and share best practice.
The future of our energy market
The transition to a new energy future is gathering pace, with technology accelerating key trends like decentralisation, digitisation and decarbonisation. To realise the benefits for consumers, we have set out three big priorities for the sector to focus on:
Ensure our system architecture meets the needs of future consumers;
Learn lessons from other sectors that have experienced disruption; and
Learn lessons from international markets.
The future of UK carbon pricing
In a response to the UK Government's consultation on the EU Emissions Trading Scheme (EU ETS) once the UK has left the European Union, we propose that the UK remains a full participant of the existing EU ETS scheme.
Find out more about our wider engagement
Response to UK Government Consultation on ethnicity pay reporting 2019
In January, we submitted our response on ethnicity pay gap reporting to improve diversity reporting.

redpajama_set_name: RedPajamaCommonCrawl


text:
Your blog talks about Neon Genesis Evangelion? Contact Us to be indexed in the BitFeed Network
Focus The Best Code Geass Cowboy Bebop Neon Genesis Evangelion
The 7 best anime original, not taken from the manga
Not always to make an anime takes its cue from its paper-based work, there are cases in which the whole series, from beginning to end, is completely original. It is, therefore, of the new creation, made by a team of specialists who have devised the plot, development, characterization and way of achieving...
Souls Neon Genesis Evangelion Psychology Shinji Hikari
Neon Genesis Evangelion: psychological therapy for use with Shinji
Who has had the opportunity to see the masterpiece of Hideaki Year, Neon Genesis Evangelion, knows well that the fulcrum of the story, the more that the battles between the mecha, is the characterization of the psychology of the characters. On the other hand, in the same Year, and has repeatedly stated...
Focus The Best Bakemonogatari Go Toubun No Hanayome Goblin Slayer Neon Genesis Evangelion
7 anime to watch this summer
The need to relate to an anime already seen does not seem to be there, after all, it is a bit like wasting time that you could invest in seeing something new. The logic of why "not about the series you've already seen" can also be understandable, and yet...There are series that cannot be understood and...
Souls Gualtiero Top Level Directory (I.e Neon Genesis Evangelion Netflix
Neon genesis Evangelion: the voice actors wanted to leave the series
As we know, Netflix has now removed the new footage below of the controversies of the fans for an adaptation that has done more dissatisfied than satisfied. But they are still to get news on the fact that not only the fans, but also professionals that we have worked, have just digested the work of Gualtiero...
Souls Hideaki Year Neon Genesis Evangelion Netflix Pornhub
Evangelion: on PornHub the first episode with voice-overs classic
The new dubbing in Italian language of the Neon Genesis Evangelion has raised many controversies (here you can find some interesting points in this regard). Due to the fact that the rights had expired, this new dubbing was necessary, but they are really in many people to the complexities of the modern...
Focus Special Gualtiero Top Level Directory (I.e Neon Genesis Evangelion Netflix
Evangelion – Netflix: how adaptation makes the dark an opera
The Italian adaptation of the anime (but not only) has always been one of the issues discussed in (a vexata questio would say ne, The Knights of the Zodiac Enrico Carabelli) when the c.d. "japanese cartoons" have had a certain spread in Italy, say, with the local networks and the transmissions of the...
Souls Focus Hideaki Year Neon Genesis Evangelion Netflix Anime
Neon Genesis Evangelion, that's when it will be available on Netflix
At the conclusion of a countdown live on their social channels official Netflix has made it known that the tv series of Neon Genesis Evangelion, which was announced last November for an expected distribution in the Spring of 2019, will be available to subscribers of the service of video on demand around...
Japan Dynit Neon Genesis Evangelion New Balance In The Manga Rebuild Evangelion
Evangelion: New Balance launches sneaker collection
New Balance has shared a series of photos that showed his collection of sneakers dedicated to Evangelion. The anime has inspired three shoe models, and each model makes reference to one of the Unit Characters, so that fans can choose the mecha that you want to represent.Adidas did DB inspired shoes but...
Focus The Best Code Geass Akito The Exiled Mobile Suit Gundam Mobile Suit Gundam Seed Neon Genesis Evangelion Star Blazers 2199 Starblazers Uchu Senkan Yamato
The 5 best battles in the anime
We suffered a premise: the japanese animation has a multitude of battles that deserve to be on this list. However, here I decided to reward especially those where you demonstrated a certain war strategy.That said, there are two battles from Star Blazers/Battleship Space Yamato, and one each from the...
Focus The Best Detective Conan The Enchanted City Neon Genesis Evangelion Your Name
The 8 souls that deserve a live-action
Even when an anime is adapted into the format of the live-action in a manner appropriate and consistent with the original product, it is not uncommon that the fans may feel disappointed by this operation. For this reason, when an animated film is in some way adapted in a different format, it is often...
Japan Dynit Gainax Neon Genesis Evangelion In The Manga Rebuild Evangelion
Neon genesis Evangelion: the uniform NERV-inspired a-line shirts
If you've always wondered how it would have been to wear the uniform of the staff at NERV, you can soon fulfill your desire, thanks to Cospa, which offers work shirts inspired by the uniforms of NERV appearing in the anime.Even if the fate of the fans of Eve is that of the suffering waiting for the new...
Japan Dynit Gainax Neon Genesis Evangelion In The Manga
Neon Genesis Evangelion inspires a new clothing line
OJ has collaborated with Neon Genesis Evangelion to offer a new line of clothing inspired by the series.ジーユーがエヴァンゲリオンと初コラボ、1週間限定のオリジナル店内放送もhttps://t.co/4Eb0tqnptU #OJ #エヴァンゲリオン pic.twitter.com/ivSrYdz5Eb— Fashionsnap.com (@fashionsnap) February 26, 2018Introducing a new visual with the characters in...
Focus The Best Berserk Cowboy Bebop Neon Genesis Evangelion Pokemon Slam Dunk
12 unforgettable anime of the '90s
Whether you are nostalgic or no, during the decade between the early '90s and the first of the new millennium, japanese animation has transmitted some of the most famous series in the history. Not only that, the 90's also gave way to some of the series that we look at it again now.A quote is fitting...


Working in an office is not without its perks, especially compared to the complicated nature of working from home. There's comradery with your co-workers, free birthday cake, built-in lunch breaks and a desk and chair you didn't have to pay for. Even so, there are some things only office workers will understand when it comes to Monday to Friday life.
Did somebody say free food? Leftover sandwiches in the lunchroom? Stale cake from yesterday's meeting? We're IN.
The clock hits 10am, time for coffee number one…ok, three. Yawns.
Only 2 hours and 57 minutes until you have a whole hour to yourself. Bliss.
Sometimes you take the stairs just to avoid making polite conversation with co-workers you hardly know.
Why isn't it socially acceptable to say you slept in, sat around and did nothing?
Birthday cards, retirement cards, congratulations cards – now you just write 'good luck' on all of them.
What IS that in the fridge? When was the last time someone cleaned the sandwich press? And who took the last clean fork?
No matter how hard you try to get out of them, meetings are never going away.


text:
Interpol arrests 27 suspects in crackdown on crime across East Africa
◄ Panama Papers reveal offshore payments by Madagascar's seafood king
Taking global action against illicit financial flows ►
by Kudzai Chinoda - Tuesday, 23 October 2018, 10:39 AM
By CONRAD AHABWE | PML Daily Correspondent
KAMPALA – Uganda Police Force has netted 27 suspects in an operation code-named usalama that is done in conjunction with countries in the region.
The operation that was carried out between 27th September to 2nd October 2018 saw countries that fall under the umbrella of the Eastern African Police Chiefs Organization [EAPCCO] And Southern Africa Police Chiefs Cooperation Organization [SARPCCO] conducting it at the same time.
"This operation targeted transnational border crimes which include, theft of motor vehicles, human trafficking, wildlife and environmental crimes, stolen documents, vandalism, narcotic drugs, illicit trade of small and light weapons and terrorism" Director INTERPOL and International Relations, Dr.Fred Yiga said this in a press conference on Friday at INTERPOL offices in Kampala.
He added that the exercise was conducted together with relevant security agencies and statutory public agencies like National Forestry Authority, Wildlife, Uganda Revenue Authority, Uganda National Drug Authority, Directorate of Public Prosecution and Immigration.
Yiga noted that 16 were arrested for being in possession of protected tree species, and were sentenced to two years in prison, five for being in possession of wildlife products like leopard skin, game meat, ivory weighing 36.4kgs, while others for vandalism, theft of motor vehicles and dealing in narcotic drugs.
Dr. Yiga highlighted the need for Kenya and Uganda to always conduct periodic regional training on the effects of drug trafficking in order to catch up with the ever-changing trends of criminals in human and drug trafficking.


William Anderson with Two Saddle-horses painting takes 14 -16days for production by an artist, and another 3 -5days for delivery. You can custom George Stubbs William Anderson with Two Saddle-horses painting on canvas, or painting with a large frame.
We deliver George Stubbs William Anderson with Two Saddle-horses worldwide at the same shipping fee of $15.00, but it is free if you buy more than one art at a time.
This is the picture of the original William Anderson with Two Saddle-horses by George Stubbs. We reproduce it with oil paint on canvas, stretched and frame; but we do not offer William Anderson with Two Saddle-horses on machine serigraph, poster, giclee or print.


A former Vancouver nurse has filed a complaint with the BC Human Rights Tribunal saying that the 12-step approach did not work to help him overcome substance abuse, but it's the only addiction program acceptable in the nursing profession and he lost his job when he stopped attending.
There's a saying in Alcoholics Anonymous: "It works if you work it." But it did not work for Byron Wood.
Wood is an atheist, and found it impossible to put his life into the hands of a higher power, as the 12 steps require. He's also trained as a nurse, and knew the scientific evidence in support of AA is far from conclusive.
"I didn't get any benefit from it; I didn't find anything therapeutic about it," Wood told CBC. "Everybody would tell me that this was not a religious program, you can believe in any higher power you want. But as somebody who doesn't believe in a god and doesn't subscribe to a religion, it was quite ridiculous."
Wood was a registered nurse, a competitive runner and a triathlete, but he was also a binge drinker who occasionally abused other drugs. He'd been in at least two car crashes while he was drinking, according to a doctor's report, but says he'd never been drunk at work.
His world came crashing down in October 2013, when he landed in the psychiatric ward of Vancouver General Hospital. He'd recently come home from a vacation filled with alcohol and drugs, and was in severe withdrawal.
In the hospital, he was diagnosed with substance use disorder. His professional college was informed, along with his union and his employer, Vancouver Coastal Health.
After his hospitalization, he continued to use, at one point suffering a near-fatal heroin overdose.
Wood was referred to an addictions specialist, who drew up a plan he'd have to follow if he ever wanted to return to work — he was under suspension while undergoing treatment. AA was a mandatory, daily element of that plan.
When Wood stopped going to meetings, he lost his job, as well as his registration as a nurse.
He'd offered to attend meetings with secular support groups, see a counsellor and undergo regular blood testing, but that alternative plan was rejected by his doctor, according to emails provided to CBC.
Wood also asked to be referred to a new doctor who could recommend secular alternatives to AA, but his union informed him that it only uses addictions specialists who follow the 12-step model, the emails show.
Researchers say Canadian nurses with addiction problems are usually required to attend 12-step programs in the interest of protecting patient safety. They're allowed little to no choice in their treatment plans.
Now 41, Wood keeps copious notes about his case, and is resolute about changing the standards for addiction treatment in B.C.
His determination has earned him a reputation for stubbornness — a union representative described him as "very difficult" in an email. But the criticism doesn't faze him.
"I asked for evidence-based treatments and it was refused to me. I don't think there's any other area of healthcare where a person isn't allowed to choose their own treatment type," he said.
Wood's story raises questions about how employers treat healthcare workers struggling with substance use disorder, and the dependence on 12-step programs and complete abstinence in some regulatory programs.
"I don't agree that, based on the evidence, this ever should have been considered to be the standard of care," said Karen Urbanoski, a scientist at the Canadian Institute for Substance Use Research in Victoria.
"There is a risk that we are going to be forcing people, or trying to force people, to engage in a service or a support that is legitimately not right for them."
Since the 12 steps were created more than 80 years ago, there's no question they've been instrumental in the recovery of many addicts around the world. In the public imagination, and in certain sectors of the medical profession, they're still seen as the best way to treat addiction.
But leading addictions researchers have long questioned the overall effectiveness of AA and its requirement for absolute abstinence. Recent decades have seen the development of numerous evidence-based pharmaceutical treatments for addiction, along with secular alternatives to 12-step programs.
These researchers say everyone needs to have choice in their treatment path, if there's to be any hope of recovery.
That isn't the case for RNs, according to Charlotte Ross, a PhD candidate at Simon Fraser University who has studied the mandatory program for nurses with substance use disorders in a western province.
To protect the privacy of her research subjects, she can't reveal which province, but says all Canadian programs for nurses are very similar, and they're all based on the 12-step philosophy.
"The standardized program is one size fits all — and it doesn't. There are some people it works for … but there's some people for whom it doesn't. And there's a whole array of other treatment options, that are based in public health, that are utilized with the general public, that nurses aren't allowed," said Ross.
Today, Wood says he no longer abuses drugs or alcohol. He got through his addiction with help from a drug called naltrexone, which blocks the intoxicating effects of alcohol and opiates. Over time, it decreases the desire to consume those substances.
It's an option he says he wasn't offered while he was still in the mandatory treatment program. A physician who recently treated Wood says the drug has produced a dramatic improvement.
Wood has filed a complaint with the BC Human Rights Tribunal, arguing that he was subjected to discrimination on the basis of religion and mental disability. Many groups have lined up behind him, saying his case is an important human rights issue.
Several experts and critics of 12-step programs have written letters to the tribunal, saying that Wood's complaint is in the public interest. His supporters include scientists, doctors, psychotherapists, lawyers, the B.C. Civil Liberties Association, the B.C. Humanist Association, and the Centre for Inquiry Canada.
The B.C. Nurses' Union and VCH are named as respondents in the complaint. Both organizations declined to comment for this story.
Though AA has been around since 1935, when it was created by two recovering alcoholics, there is little decisive scientific evidence supporting its use.
Less a medical treatment than a fellowship, Alcoholics Anonymous is a sort of group therapy, originally rooted in Christianity. The 12 steps require members to "turn our will and our lives over to the care of God as we understood Him," admit their faults, and make amends with those they've hurt.
Proponents say it's helped millions rebuild their lives, and can work for anyone who's really committed to the program. The Greater Vancouver Intergroup Society, which runs AA meetings in the region, says the organization is not religious, but there are some secular meetings that use versions of the 12 steps that have been adapted for atheists and agnostics.
But there are those like Wood who object to the religious leanings of AA, and question how effective it really is.
A 2006 Cochrane review of the available research on the issue found that "the available experimental studies did not demonstrate the effectiveness of AA or other 12-step approaches." A new review is currently underway.
According to Dan Reist, an assistant director at the Canadian Institute for Substance Use Research, most peer-reviewed studies have shown that AA is not particularly effective.
"Does it have behind it some good scientific studies of cause and effect that is often claimed by the proponent? The answer to that is: No, it doesn't," he said.
There is strong evidence that AA works for certain people, Reist added, but only those who want to be there.
"The idea that we can simply grab people, force them into a situation where we can fix them, misunderstands the very nature of addiction. That's what's wrong in the Byron Wood case," Reist said.
After Wood lost his job, he filed a complaint with the College of Physicians and Surgeons of B.C. against the addictions specialist who treated him, alleging religious discrimination and inadequate treatment — among other things.
That complaint was dismissed. And so Wood appealed to the Health Professions Review Board, which provides independent reviews of decisions from professional regulators in B.C., claiming the college's investigation had been inadequate.
But that was dismissed this summer — the review board said the doctor had acted within the "community standard" for addictions treatment, and that the college's inquiry committee cannot be expected to settle scientific debates about the merits of AA.
Wood is planning to file for a judicial review of that decision.
Dr. Galt Wilson, senior deputy registrar for the physicians' college, defended the treatment plan drawn up for Wood.
He wrote in an email that addictions experts who treat people in "safety-sensitive occupational roles" like nursing recommend abstinence-based recovery, including the 12 steps.
Wilson acknowledged that the scientific evidence on AA is not conclusive, but cited a 2008 study of 12-step-based addictions programs for American doctors, which found "significant positive outcomes." That study did not include a control group, or compare the outcomes for physicians who did not take part in 12-step meetings.
Does AA get an 'F' for treating alcoholics?
Meanwhile, the College of Registered Nurses of B.C. said that treatment programs for RNs are developed at the discretion of medical specialists in addiction.
"Ultimately, it is up to the employer to decide whether a nurse keeps their job," the college said in a written statement.
Wood is currently waiting to see if his human rights complaint will be allowed to proceed. In the meantime, he's healthy and working as a landscaper.
He said his prescription for naltrexone has changed everything.
"Since taking that, I've been able to drink alcohol moderately, and abstain from other drugs," Wood said.
He said he now has a beer every one or two weeks — and sometimes, he doesn't even want to finish his drink.
In June, 1,234 prescriptions for naltrexone were filled in B.C., according to the ministry of health. The researchers interviewed for this story cautioned that, like every other available addiction treatment, naltrexone does not work for everyone.
But a prominent B.C. addictions physician who recommended the drug to Wood wrote in an affidavit for the review board that the drug has had a "transformative effect" on his patient.
He also suggested that the rigid requirement to attend AA meetings actually contributed to Wood escalating his drug use after he was hospitalized — leading to a near-fatal heroin overdose.
These days, Wood says he misses working as a nurse, but he's not sure he would be in such a healthy place if he'd continued with the original treatment plan.
"It's one of the most basic things in healthcare, that a patient is supposed to have the right to choose their own healthcare — voluntary, informed consent — and I wasn't given that," he said.


Get these charts that provide coverage of Denmark, Faroe Islands, Finland, Norway and Sweden. These charts fit into three 2-inch binders, which are sold separately.
The Airway Manual is an all-paper manual that is designed for the IFR pilot who requires the most up-to-date and complete planning, enroute and terminal information.
For each geographic area that you select, you receive a complete set of initial enroute charts, area charts, terminal charts, flight procedures and supplemental information. Your service will then be kept current throughout the year via updates and revisions.


Home > Scores > Ensembles > Piano Four Hands Sheet Music > Intermediate Piano Four Hands Sheet Music > Which Ride To Choose?
Jennifer Watts: Which Ride To Choose? for piano four hands, intermediate sheet music.
About "Which Ride To Choose?"


text:
Download citation information
Standard abbreviations
Need Help? E-mail the JCI
Article Free access | 10.1172/JCI6067
Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy
Jil C. Tardiff,1,2 Timothy E. Hewett,3 Bradley M. Palmer,4 Charlotte Olsson,4 Stephen M. Factor,5 Russell L. Moore,4 Jeffrey Robbins,3 and Leslie A. Leinwand1
1Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colorado 80309, USA2Division of Cardiology, Albert Einstein College of Medicine, Bronx, New York 10461,USA3Department of Pediatrics, Division of Molecular Cardiovascular Biology, Children's Hospital Research Foundation, Cincinnati, Ohio 45229, USA4Department of Kinesiology and Applied Physiology, University of Colorado, Boulder, Colorado 80309, USA5Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA
Address correspondence to: Leslie A. Leinwand, Department of Molecular, Cellular and Developmental Biology, University of Colorado, Campus Box 347, Boulder, Colorado 80309, USA. Phone: (303) 492-7606; Fax: (303) 492-8907; E-mail: leinwand@stripe.colorado.edu.
Find articles by Tardiff, J. in: JCI | PubMed | Google Scholar
Find articles by Hewett, T. in: JCI | PubMed | Google Scholar
Find articles by Palmer, B. in: JCI | PubMed | Google Scholar
Find articles by Olsson, C. in: JCI | PubMed | Google Scholar
Find articles by Factor, S. in: JCI | PubMed | Google Scholar
Find articles by Moore, R. in: JCI | PubMed | Google Scholar
Find articles by Robbins, J. in: JCI | PubMed | Google Scholar
Find articles by Leinwand, L. in: JCI | PubMed | Google Scholar
First published August 15, 1999 - More info
Published in Volume 104, Issue 4 on August 15, 1999
J Clin Invest. 1999;104(4):469–481. https://doi.org/10.1172/JCI6067.
© 1999 The American Society for Clinical Investigation
First published August 15, 1999 - Version history
Received: December 15, 1998; Accepted: July 1, 1999
Multiple mutations in cardiac troponin T (cTnT) can cause familial hypertrophic cardiomyopathy (FHC). Patients with cTnT mutations generally exhibit mild or no ventricular hypertrophy, yet demonstrate a high frequency of early sudden death. To understand the functional basis of these phenotypes, we created transgenic mouse lines expressing 30%, 67%, and 92% of their total cTnT as a missense (R92Q) allele analogous to one found in FHC. Similar to a mouse FHC model expressing a truncated cTnT protein, the left ventricles of all R92Q lines are smaller than those of wild-type. In striking contrast to truncation mice, however, the R92Q hearts demonstrate significant induction of atrial natriuretic factor and β-myosin heavy chain transcripts, interstitial fibrosis, and mitochondrial pathology. Isolated cardiac myocytes from R92Q mice have increased basal sarcomeric activation, impaired relaxation, and shorter sarcomere lengths. Isolated working heart data are consistent, showing hypercontractility and diastolic dysfunction, both of which are common findings in patients with FHC. These mice represent the first disease model to exhibit hypercontractility, as well as a unique model system for exploring the cellular pathogenesis of FHC. The distinct phenotypes of mice with different TnT alleles suggest that the clinical heterogeneity of FHC is at least partially due to allele-specific mechanisms.
J. Clin. Invest.104:469-481 (1999).
Familial hypertrophic cardiomyopathy (FHC) is a dominant disease of the cardiac sarcomere. Mutations in many components of the thick and thin filaments have been identified, including the β-myosin heavy chain (β-MyHC), both myosin light chains, myosin-binding protein C tropomyosin (α-TM), cardiac troponin T (cTnT), and troponin I (TnI) (1). Thus, the disease is genetically heterogeneous. The types of mutations that have been found in the genes are also quite varied. For example, most of the mutations in the β-MyHC are missense mutations, whereas mutations in the cTnT and myosin-binding protein C genes can be splice-site mutations, deletions of codons, and missense mutations. The disease is also clinically heterogeneous, with some mutant alleles resulting in a poor clinical prognosis, whereas others are associated with a good prognosis (2). In general, mutations in the β-MyHC gene are associated with moderate to severe ventricular hypertrophy and variable sudden death, whereas mutations in cTnT are associated with mild or no hypertrophy and a high incidence of sudden death. The fact that all the mutations implicated in this disease are in genes encoding sarcomeric proteins has led to the suggestion that the pathogenesis of the disease likely involves a common mechanism of contractile dysfunction.
Several approaches have been used to understand mechanisms of pathogenesis, as well as the basis for the observed clinical heterogeneity. In vitro biochemical approaches have demonstrated that mutations in the β-MyHC function through a dominant negative mechanism and that several mutants have defects in actin-activated ATPase activity (3–5). This reduction in motor activity presumably triggers a compensatory hypertrophic response, explaining the high frequency of hypertrophy in patients with MyHC mutations. Transgenic mouse models have been created for mutations in the cardiac MyHC, and these models have both similarities and differences with each other and with the human disease. Both models exhibit many of the histological features of the disease; one exhibits significant ventricular hypertrophy, whereas the other exhibits no ventricular hypertrophy (6, 7).
Structurally, cTnT interacts directly with TM along extended regions that span the head-to-tail region of the contiguous array of TMs within the thin filament and is thought to promote the ordered assembly of the Tn-TM complex onto the actin filament (8). The 3′ end of the molecule also binds the TnI-TnC complex. In low-Ca2+ states (relaxation), TnT binding to TnI-TnC allows the inhibition of the myofibrillar actomyosin MgATPase by TnI. This effect is overcome at higher [Ca2+] (contraction), where the binding of Ca2+ to TnC favors the reformation of the permissive TnI-TnC complex (9). Thus, the ability of the thin filament to respond to shifts in Ca2+ within the myocyte is modulated by multiple protein-protein interactions that occur along the cTnT molecule. Both skeletal and cardiac muscle TnT are expressed as multiple isoforms, and it has been postulated that this allows flexibility in adapting to physiological changes. Since the initial mapping of the cTnT-related FHC alleles in 1994, several in vitro studies have been performed using human and rat cTnT alleles in an attempt to better understand the effects of these mutations at the level of the cardiac sarcomere (10). Using a primary quail myocyte culture system in transfection studies, Watkins et al. (11) were able to demonstrate that full replacement of the native quail TnT with a truncated form of human cTnT (deletion of exon 15) resulted in a much-diminished maximal force of contraction. The mechanism of this decrease in Ca2+-activated maximum force remains unclear, although it is possible that this effect is due to an alteration in the Ca2+ sensitivity of the thin filament caused by the partial deletion of the TM-TnI-TnC binding site. Point mutations in the TM binding site (I79N and R92Q) have been studied in a variety of systems, including adenovirus infection of feline cardiac myocytes, in vitro reconstitution assays, and cTnT exchange studies using permeabilized rabbit cardiac muscle fibers (12–14). Although the results have varied depending on the experimental system, several key observations have emerged, including decreased contractile performance, increased thin filament sliding speed in an in vitro motility assay, and increased Ca2+ sensitivity. In particular, it appears that point mutations in the TM binding site do not result in changes in maximal force-generating capability (14). This is in contrast to in vitro studies performed on several of the β-MyHC alleles, wherein the observed contractile impairment has been postulated to result in a compensatory hypertrophic response (15). Most recently, 3 additional cTnT-related FHC alleles were analyzed in transfected quail skeletal myotubes (I79N, R92Q, and Δ160). All 3 mutants showed a decreased Ca2+ sensitivity of force production, whereas a subset (I79N and R92Q) exhibited an increased velocity of shortening (16). The reason for this difference in Ca2+ sensitivity in 2 different studies is unclear and will likely require additional experimentation.
We recently described a transgenic mouse model for the truncated allele of cTnT and found that the hearts of these animals develop a severe cardiomyopathy with significant myocellular disarray but no apparent fibrosis (17). Surprisingly, the hearts of these animals are significantly smaller than those of controls. The reduction in ventricular mass could be explained by the observation that there are fewer myocytes and that those that are there are smaller than controls. In addition, the hearts develop severe diastolic dysfunction and milder, but significant, systolic dysfunction. Although no reports of sudden death in the mutant MyHC mice have been reported, mice that express approximately 10% of their cTnT as the truncation mutant die within 8 hours of birth. In contrast, a recent report of a transgenic mouse expressing a different allele of cTnT (R92Q) demonstrated no alterations in chamber dimension or systolic function, but a reduction in diastolic function when hearts contain 1–10% of their cTnT as this mutant (18). We report here significantly different findings, with mice expressing 30%, 67%, and 92% of their cTnT as the same R92Q mutant allele. Just as in the case of the truncated cTnT allele, the hearts of these animals are significantly smaller than those of controls. In contrast, they exhibit significant dose-dependent fibrosis. They also demonstrate enhanced systolic function in the presence of diastolic dysfunction, consistent with the hypothesis that at least some TnT mutant alleles result in a hypercontractile heart. While hypercontractility is a common finding in patients with FHC (19, 20), the cause remains unclear, and these animals provide clear insight into that phenotype, as we show here that the cells themselves are hypercontractile. In addition, electron micrographic analysis demonstrates little degeneration of the myofibrils but, instead, gross alterations in mitochondrial morphology and increases in mitochondrial numbers along with lipid deposition. These ultrastructural findings are distinct from those of the hearts of mice expressing the truncated TnT allele, which show myofibrillar disarray.
Clone construction and screening. A full-length (1,089 nucleotide) adult mouse cTnT cDNA clone was isolated from a BALB/c mouse cardiac λgt11 cDNA library (CLONTECH Laboratories Inc., Palo Alto, California, USA) and cloned into Bluescript KS+ (Stratagene, La Jolla, California, USA). The full-length cDNA (WT) was tagged at the NH2-terminus with an 11–amino acid human c-myc epitope by PCR using Vent DNA Polymerase (New England Biolabs Inc., Beverly, Massachusetts, USA) (21). The 5′ oligonucleotide (containing sequence for the c-myc tag and MluI-EcoRI restriction sites) ACGCGTGAATTCTAATGGTGGAGCAAAAGCTCATTTCTGAAGAGGAGGACTTGTCTGACGCCGAGGAGGTGGTG was paired with the 3′ oligonucleotide CCGAAGCTTTCATCATTTCCAACGCCCGGTGACTTTG. The resultant DNA fragment was subcloned into Bluescript, and the sequence was verified by Thermal Cycle sequencing. The R92Q construct was generated by oligonucleotide mutagenesis. A 5′ internal oligonucleotide including a naturally occurring Bsu36I site was paired with a 3′ oligo containing both a dinucleotide missense mutation and an internal AlwNI restriction site. A 220-bp internal fragment was generated by PCR and Pfu polymerase (Stratagene) using the WT-Bluescript clone as a template. The resultant fragment was subcloned into PCR-Blunt (Invitrogen Corp., Carlsbad, California, USA), sequenced, and reisolated as a Bsu36I-AlwNI fragment. The original WT-Bluescript construct was digested with Bsu36I and AlwNI to isolate the 2 fragment arms and then gel purified. The internal R92Q fragment was ligated to 2 fragments isolated as just described in a 3-part ligation to produce in a 5′ myc-tagged R92Q construct (R92Q-Myc). The R92Q-Myc Bluescript construct was digested with MluI-EcoRV, and the isolated fragment was ligated to a preexisting vector containing –2,996 bp of 5′ upstream sequence from the rat α-MyHC promoter and 1,500 bp of the mouse βmaj globin terminator separated by a multiple cloning site (22). The resultant transgene constructs are digested with KpnI to isolate a 5.5-kb linear fragment and used in microinjections. The transgene was injected into the pronuclei of CBA/B6 fertilized mouse eggs derived from an F1 cross between FVB/N and C57/B6 strains (23). Founders were screened by Southern analysis of tail DNA using a 650-bp internal transgene probe. All F1 and subsequent screenings are performed by PCR using a pair of transgene-specific primers: 5′ (αPromoter) ACCTAGAGGGAAAGTGTCTT and 3′ (Myc-TnT) TCCTCTTCAGAGATGAGCTTT. All PCR reactions contained the internal control housekeeping primers Mus1 (TGAGGTTGTCTTCTGATCTGC) and Mus2 (TCCTGGACAAAGTAACCCTTG).
Cardiac protein isolation and Western analysis. Crude cardiac protein and myofibril isolation and subsequent SDS-PAGE/Western analysis were performed as described previously (17).
Ultrastructural analysis. Five-week-old mice were sacrificed, and the hearts were immediately excised and rinsed in ice-cold PBS + 1 mM EDTA. Each heart was successively immersed in 10, 20, and 30% ice-cold sucrose solution (wt/vol in PBS + 1 mM EDTA) for 15 minutes (each step) on ice. Hearts were taken from the 30% sucrose solution, cut into small blocks, and immediately transferred to fresh ice-cold 4% paraformaldehyde and 1% glutaraldehyde in 0.1 M PBS with 5% sucrose (wt/vol) for 24 hours. The tissue was washed several times in buffer and postfixed for 1 hour in 1% osmium tetroxide. After several rinses in buffer, the tissue was dehydrated in ascending ethanol solutions, cleared in acetonitrile, and infiltrated in a mixture of Araldite-Epon. The tissue blocks were subsequently flat-embedded. Toluidine blue–stained sections (1 μm) were first examined by light microscopy, and well-oriented (longitudinal) tissue blocks were then cut for thin sections, stained with uranyl-acetate and lead-citrate, and examined with a JEOL-100CX electron microscope (JEOL USA Inc., Cranford, New Jersey, USA).
Northern analysis. Isolation of total RNA from mouse hearts was performed as described by Chomczynski and Sacchi (24). A total of 10 μg of total RNA from each source was separated on an 0.8% agarose-formaldehyde gel, transferred to a nylon membrane (ICN Biochemicals Inc., Costa Mesa, California, USA), and sequentially hybridized with a series of radiolabeled DNA probes. Unique single-stranded oligonucleotide sequences corresponding to α-MyHC (5′-GAGGGTCTGCTGGAGAGG-3′) and β-MyHC (5-TGTTGCAAAGGCTCCAGGTCTGAGGGCTTC-3′) were end-labeled and added to hybridization solution composed of 7% SDS, 10× Denhardt's solution, 20 mM NaPO4 (pH 7.2), 5× SSC, and 0.2 mg/mL denatured salmon sperm DNA. The blots were hybridized overnight at 55°C. Sequential washes were performed (2× SSC/0.1% SDS, 1× SSC/0.1% SDS, 0.5× SSC/0.1% SDS) at 42°C, and the blots were exposed overnight with an intensifying screen at –70°C. Restriction fragments of GAPDH, atrial natriuretic factor (ANF), murine cTnT, and SERCA2 cDNA sequence were isolated and labeled by random priming. Hybridizations were performed overnight at 65°C in the following hybridization solution: 5× SSC, 1× Denhardt's solution, 10% dextran sulfate, 50% formamide, 1% SDS, and 0.2 mg/mL denatured salmon sperm DNA. Washes were performed as already described at 65°C and with an added wash with 0.1× SSC/0.1% SDS. Blots were exposed overnight with an intensifying screen at –70°C.
Isolated perfused working heart preparation. These studies were carried out as described previously (17).
Adult cardiac myocyte isolation. Ventricular cardiocytes were obtained from control, wild-type, and transgenic mice using a modification of the protocol described by Wolska and Solaro (25). All chemical and reagents were obtained from Sigma Chemical Co. (St. Louis, Missouri, USA) except as noted. Mice were heparinized (250 U, intraperitoneally) 15 minutes before administration of an anesthetic dose of sodium pentobarbital (35 mg/kg body weight, intraperitoneally; Abbott Laboratories, North Chicago, Illinois, USA). Under deep anesthesia, hearts were exposed by midline thoracotomy and were rapidly excised and placed in ice-cold (0–2°C) saline solution. An 18-gauge stainless steel cannula was fixed in the aorta with 6-0 surgical silk suture, and each heart was retrogradely perfused (75 cmH2O perfusion pressure) with an oxygenated (95% O2/5% CO2) nominal Ca2+-containing modified Krebs-Henseleit (KH) buffer (pH 7.4, 37°C) for 4 minutes. Hearts were then perfused (45 cmH2O perfusion pressure) for an additional 10–15 minutes with a similar modified KH buffer that contained collagenase (375 U/mL; Worthington Biochemical Corp., Lakewood, New Jersey, USA) and 50 μM CaCl2. Hearts were removed from the cannula, and the atria and aorta were trimmed away and discarded. The remaining left and right ventricular myocardium was minced and mechanically agitated for 6–8 minutes in modified KH buffer (37°C, pH 7.4) containing 100 μM CaCl2. The resulting cell suspension was gently subjected to 7–10 passes through a 10-mL plastic culture pipette and was filtered through a 250-μm nylon mesh filter. A total of 10 mM 2,3-butanedionemonoxime (BDM) was present in all perfusates and cell isolation buffers throughout the protocol. Cells from each experimental group were divided into 2 aliquots and allowed to passively settle for 7 minutes. One cell pellet was resuspended in a bicarbonate-based Medium 199, and the other pellet was resuspended in Medium 199 containing 10 mM BDM. Cell suspensions were then plated onto laminin-coated glass coverslips and incubated for 2–8 hours at 37°C with 5% CO2/20% O2.
Cell morphology and myocyte-shortening dynamics. Coverslips from each experimental group (control, wild-type, and transgenic) and subgroup (+/– BDM) were microscopically examined (Nikon Diaphot, ×40 lens; Nikon Corp., Melville, New York, USA), and images of cardiocytes were recorded onto videotape. Video images of individual cardiocytes were analyzed for maximal length, midpoint width, and area using Image 1.41 software (National Institutes of Health, Bethesda, Maryland, USA). To assess myocyte-shortening dynamics, additional coverslips (Medium 199 without BDM) were used to form the bottom of a custom-built flow-through chamber (26). The chamber was placed on the stage of an inverted microscope (Nikon Diaphot) fitted with a ×40 oil-immersion objective (Fluor 40, numerical aperture = 1.30). Coverslips were superfused with a normal Tyrodes solution (in mM: 140 NaCl, 6 KCl, 1 MgCl2, 2 CaCl2, 10 glucose, 2 pyruvate, and 5 HEPES [pH 7.4]) and maintained at 29°C. Cardiocytes were electrically paced at 0.5 Hz by field stimulation using platinum electrodes with a 0.5-microsecond stimulus duration at an intensity of 1.5× threshold. Myocyte contractile activity was assessed by video edge detection (Crescent Electronics, Sandy, Utah, USA) and recorded using an A-to-D converter and a microcomputer. Custom-made software was used to analyze cardiocyte-shortening transients, and the following characteristics were analyzed: maximal extent of shortening, time to peak shortening, maximal shortening and relengthening velocities (μm/s), maximal rates of shortening and relengthening (s–1), and time to 50% relaxation. Sarcomere lengths were assessed from white-light video images taken using a Nikon ×100 oil-immersion lens equipped with commercially available software (IonOptix Corp., Milton, Massachusetts, USA).
Statistical analysis. The myocyte morphology data were analyzed using a 2-way (group × BDM) ANOVA. Myocyte-shortening data were analyzed using a 1-way ANOVA. In both types of analyses, statistical differences were identified at the P < 0.05 and P < 0.10 levels. The latter significance criterion was used following the principles described by Williams et al. (27). Briefly, examination of data at the P < 0.10 level reduces the probability of committing a type II error (accepting the null hypothesis when it is false), and may be more appropriate for exploratory (rather than confirmatory) investigation. In our statistical analysis, we ascribed to the principle that in an investigation of myocyte properties, myocytes serve as the best proxy to themselves. This approach maximizes statistical power and enhances the chance of detecting between group differences, but it does so at the expense of strictly satisfying the data sampling independence assumption. Strict satisfaction of the sampling independence assumption could have only been achieved had we (a) been able to pool cells from all the hearts used in the study and sampled from a common pool or (b) used hearts as the unit of analysis. The former option was not technically practical and would have resulted in a marked reduction in the number of cells we could have sampled. The latter option would have created an analytical scenario in which we would have had virtually no statistical power and would have assumed a large exposure to type II errors.
Generation of R92Q-Myc transgenic mice. All the known cTnT-related FHC alleles in humans map within 2 major functional domains (28, 29). Our previously described cTnT-FHC transgenic mouse model demonstrated the pathophysiological effects of disrupting the COOH-terminal α-TM-TnI-TnC binding domain of cTnT (17). To determine whether mutations in different functional domains could account for some of the diverse clinical phenotypes observed in patients with FHC, we chose a common mutational site in the α-TM binding domain located at codon 92 (Figure 1a) (29, 30). The R92Q mutation has been identified in 4 independent families presenting with FHC (28). A cardiac-specific transgenic construct was generated to express a murine cTnT molecule containing a dinucleotide change that results in the substitution of a single amino acid (R→Q) at codon 92 (Figure 1b; R92Q-Myc). Both the mutant and wild-type proteins are myc-tagged at their NH2-termini. We have previously shown that the presence of the 11–amino acid c-myc epitope on the NH2-terminus of the native murine cTnT molecule does not result in cardiac pathology (17).
R92Q-TnT and truncation-TnT map to 2 distinct functional domains. (a) Exon composition of human cTnT, with positions of disease alleles Arg92Gln and intron 15 G→A marked above. The representative murine transgene allele is in parenthesis below. Tr-Myc represents a loss of exons 15 and 16. Functional domains are depicted by filled bars, with associated protein binding sites below. Location of translational start and stop codons are represented by ATG and TAG, respectively. (b) Constructs used to generate wild-type (WT) and Arg92Gln (R92Q) Myc-tagged murine cardiac TnT.
The R92Q-Myc construct was used to generate 5 independent lines of transgenic mice. Founder animals were identified by Southern analysis (data not shown). The addition of the 11–amino acid c-myc epitope to the 5′ end of the cDNA construct generates a transgenic protein with a slightly slower mobility relative to endogenous cTnT in SDS-PAGE gels. This allows unambiguous identification of the transgene protein by Coomassie staining (Figure 2a). Myofibrils were isolated from 3 independent R92Q-Myc lines, a WT-Myc animal, and a nontransgenic (non-Tg) sibling. Equal amounts of myofibril proteins were loaded on an SDS-PAGE gel, and protein was detected by Coomassie staining. The transgene protein is clearly visible in all transgenic lanes (Figure 2a). Subsequent densitometry performed on a representative gel revealed that each transgenic line has a unique Tg-cTnT/endogenous-cTnT ratio. As has been previously noted in transgenic mouse models overexpressing contractile proteins, the level of endogenous cTnT protein is clearly decreased in response to increasing levels of transgene expression (31). Thus, each independent R92Q line can be distinguished by the relative level of endogenous cTnT replacement. Three representative lines were chosen for further study that express 30%, 67%, and 92% of their total cTnT as the transgenic form. To verify that the putative transgene band shown in Figure 2a did correspond to the R92Q-Myc protein, an identical set of SDS-PAGE gels was run, blotted onto nitrocellulose, and probed with either a c-myc (Figure 2b, top) or cTnT (Figure 2b, bottom) mAb. The cTnT mAb clearly detects both endogenous cTnT and the transgene, and again demonstrates the relative levels of replacement seen in the transgenic lines. Thus, all subsequent phenotypic comparisons between lines can be directly correlated to the dosage of R92Q-Myc protein. Even with very high transgene/endogenous cTnT ratios (including near-replacement of cTnT with the mutant form), the overall myofibrillar stoichiometry is not altered (Figure 2c).
Expression of WT-Myc and R92Q-Myc proteins in cardiac tissue. (a) Coomassie-stained SDS-PAGE gel of myofibrils isolated from non-Tg (NT), WT-Myc (WT), and 3 independent R92Q-Myc lines. A total of 5 μg myofibril protein was loaded per lane. Addition of the c-myc epitope tag decreases the mobility of the Tg protein (Tg) and allows unambiguous identification. Percentages (30%, 67%, 92%) represent Tg/endogenous cTnT ratios for the 3 R92Q-Myc lines. (b) Western blot analysis of myofibrils subjected to the same SDS-PAGE conditions as noted in a. Identical blots were probed with either a c-myc or cTnT mAb as indicated. The cTnT MAb detects both Tg and endogenous cTnT, and their relative positions are marked by arrows. The additional band immediately above the cTnT band (seen best in the NT lane) represents a known murine cTnT isoform. Note the progressive decrease in endogenous cTnT protein amounts among the 3 R92Q-Myc lines. (c) Myofibrils were purified from mouse hearts, subjected to SDS-PAGE, and Coomassie stained. Myofibrillar stoichiometry is maintained in all Tg lines. (d) Fractionation of cTnT. Three separate fractions were analyzed (T = total, S = supernatant, and P = pellet). Immunoblots of fractions from non-Tg (NT), WT-Myc (WT), and R92Q-67% (R92Q-Myc) were loaded for equal signal intensity and probed with either a cTnT (non-Tg) or c-myc (WT-Myc and R92Q-Myc) mAb as indicated. No Tg protein was detected in the S fraction for either WT-Myc or R92Q-Myc. (e) Transgene protein incorporation. Shown are confocal images of isolated adult cardiac myocytes probed with either c-myc (top; R92Q-67%) or TnT (bottom; non-Tg) mAb. ×4,300.
As was previously noted, the R92Q mutation occurs at a site known to be involved in the interaction of the troponin complex with α-TM (29). Thus, it is important to determine whether the R92Q-Myc protein is able to incorporate into the native myofibril. Crude heart homogenates were isolated from transgenic and nontransgenic mice and subjected to low-speed centrifugation in low-salt conditions. Equal aliquots from each subsequent fraction were analyzed by Western blotting, and representative results are shown in Figure 2d. Myofibrillar proteins are known to pellet under these conditions, as can be seen in Figure 2d (top). Identical results are obtained with homogenates isolated from either WT-Myc or the R92Q-Myc mice (Figure 2d, middle and bottom, respectively). Thus, neither the addition of the c-myc epitope alone (WT-Myc) nor the R92Q mutation results in any alteration in the ability of the transgenic proteins to associate with native myofibrils. In addition, indirect immunofluorescence on isolated adult cardiac myocytes using the c-myc mAb revealed a clear striated sarcomeric staining pattern (Figure 2e, top), which also indicates that the transgene proteins incorporate into the cardiac sarcomere.
R92Q-Myc mice demonstrate dose-dependent changes in chamber mass. One of the main characteristics that distinguishes cTnT-related FHC from the β-MyHC form is the degree of ventricular hypertrophy. Although there is phenotypic variation both between the different disease alleles and within affected families, most patients who are heterozygous for the cTnT mutations exhibit mild or no apparent ventricular hypertrophy (28). To determine whether the cardiac-specific expression of the R92Q-Myc protein would result in changes in cardiac mass, chamber weight/body weight ratios were compared among WT-Myc, all 3 lines of R92Q-Myc, and non-Tg sibling mice. Atrial hypertrophy was found in R92Q-Myc mice that was both progressive over time and increased proportionally with transgenic protein levels (Figure 3a). This increase in atrial mass was readily apparent at 4 weeks of age in the 92% R92Q-Myc line. Although both the left and right atria are affected, a clear left atrial predominance developed with increasing age and protein levels (data not shown). In contrast, ventricular mass decreased by approximately 18% in all 3 R92Q-Myc lines (Figure 3b). There was no variation in the degree of decrease in ventricular size between the 3 lines, and these findings are consistent in animals up to 1 year of age.
Heterozygous R92Q-Myc mice demonstrate decreased ventricular mass and dose-dependent changes in atrial mass. (a) Atrial weight/body weight ratios (milligram of chamber weight per gram of body weight [BW]) in 4- to 6-month-old animals. Error bars represent SEM. P values are vs. non-Tg (NT) animals (1-way ANOVA). (b) Ventricular weight/body weight ratios from the same mice as shown in a. *P < 0.0001.
Myocytes isolated from R92Q-Myc hearts are smaller than either WT-Myc or non-Tg controls. To determine whether the decrease in ventricular mass was reflected by a decrease in myocyte size, cells were isolated from the hearts of 67% R92Q mice and measured in the presence and absence of BDM. Subsequent video image analysis of ventricular myocytes incubated in the presence and absence of BDM yielded several very interesting results. BDM is known to disrupt force-producing cross-bridge formation in mammalian myocardium (32). An important finding of this analysis was that the mean area of R92Q myocytes was approximately 18% smaller than the areas of non-Tg or WT-Myc myocytes in the presence or absence of BDM (Table 1). However, R92Q-Myc cells are significantly longer and narrower in the presence of BDM. This observation is consistent with the idea that myocyte volume under isotonic conditions is reasonably stable, and with the observation that BDM-induced increases in cell length are accompanied by decreases in myocyte width (see later here). This difference in myocyte size provides an explanation for the observation that the ventricular mass of R92Q hearts is approximately 18% smaller than the mass of non-Tg hearts. ANOVA and inspection of the data in Table 1 clearly indicate that in quiescent cells, BDM elicits an increase in myocyte length and a decrease in midpoint myocyte width. BDM produces increases in mean myocyte length of less than 3% in non-Tg and WT-Myc cells, while producing an approximately 12% increase in the length of R92Q-Myc myocytes (Table 1). The ANOVA group × BDM interactions in the myocyte length and width data (Table 1) provide statistical verification that the effect of BDM on myocyte length and width is greatest in R92Q-Myc cells. In addition, no significant between-group differences in myocyte length were detected in the presence of BDM.
Isolated ventricular myocyte morphology
In a follow-up study, left ventricular myocytes were isolated from non-Tg and transgenic mice in order to determine the effects of transgene expression and BDM on sarcomere lengths. The results of these studies are summarized in Table 2. At baseline (–BDM), sarcomere lengths in the R92Q-Myc cells were shorter than those isolated from their non-Tg siblings. After treatment with 10 mM BDM, sarcomere lengths increased by 5% (non-Tg), 9.7% (R92Q-67%), and 12% (R92Q-92%). These results are consistent with the observed myocyte length increases (+BDM) of approximately 3%, 13%, and 15% for non-Tg, R92Q-67%, and R92Q-92%, respectively. Collectively, these data suggest that the basal level of contractile element activation in quiescent R92Q-Myc myocytes is abnormally high.
Sarcomere length (μm) in isolated adult cardiac myocytes
R92Q-Myc mice exhibit characteristic histopathological findings of FHC. The histopathological findings in FHC encompass a wide range of largely primary myocellular defects. The most common observations include myocellular disorganization, degeneration, and hypertrophy (19). In addition, many patients exhibit varying degrees of myocardial fibrosis and intimal thickening of small intramural arteries (33). The frequency and myocardial distribution of these findings vary widely and appear to reflect the clinical and genetic heterogeneity of the disease. Histological examination of cardiac sections from adult R92Q-Myc mice reveals a broad range of myocellular abnormalities (Figure 4, a–f). A representative section from the R92Q-Myc-67% line is shown in Figure 4b and shows scattered hypertrophied cells and mild inflammation amid varying degrees of myocellular degeneration. Markedly pleotrophic nuclei are also present. These regions are scattered primarily throughout the left ventricular free wall. Trichrome staining for collagen deposition reveals small areas of myocardial and perivascular fibrosis (Figure 4c). The degree and distribution of these findings are virtually identical between the 30% and 67% replacement lines. Although sections from R92Q-Myc-92% mice reveal qualitatively similar histopathology, it is much more severe and extensively distributed throughout the myocardium (Figure 4e). In particular, there are frequent foci of degenerating cardiac myocytes (note the hyperchromatic cells) and striking myocellular disarray. Evidence of myocyte necrosis and inflammatory change was also observed. Trichrome staining demonstrates widespread myocardial fibrosis in the higher-expressing 92% replacement line (Figure 4f). Cardiac sections from adult WT-Myc mice (Figure 4d) are indistinguishable from those from non-Tg controls (Figure 4a).
R92Q-Myc mice demonstrate myocellular disarray and fibrosis. Cardiac sections from 4- to 5-month-old non-Tg (a), R92Q-Myc-67% (b and c), WT-Myc (d), and R92Q-Myc-92% (e and f). a,b,d, and e were stained with hematoxylin and eosin. Note markedly pleiotropic nuclei and myocellular degeneration in b and e. e also demonstrates clear myocellular disarray and inflammation. c and f are stained with Masson's trichrome and demonstrate dose-dependent myocardial fibrosis. All panels ×400.
Ultrastructural analysis of R92Q-Myc hearts demonstrates allele-specific pathology. All the alleles that have been linked to FHC map to structural components of the cardiac sarcomere (2). To assess whether the incorporation of either the R92Q-Myc cTnT or our previously described cTnT-Myc-truncation protein would result in ultrastructural abnormalities at the level of the individual cardiac myocyte, electron microscopy was performed on hearts isolated from 5-week-old mice (Figure 5, a–f). Figure 5, a and b (non-Tg and WT-Myc, respectively), demonstrates normal sarcomeric structure, with full registration of Z bands and an ordered array of clearly defined thick and thin filaments. Mitochondrial morphology, size, and number are all within normal limits. In contrast, sections from cTnT-Myc-truncation mice (Figure 5, c and d) reveal areas of focal myofibrillar lysis, misregistration of Z bands, and distinct regions of myofibrillar disarray. These findings are consistent with those found in patients with cardiomyopathies (34). Figure 5, e and f, shows representative sections from 2 independent lines of R92Q-Myc mice (67% and 92% replacement, respectively). Sarcomeric structure was found to be intact; thus, the incorporation of the mutant protein does not appear to have a direct deleterious effect on myofibrillar organization. However, the R92Q-Myc myocytes exhibited a striking degree of lipid deposition and increased numbers of mitochondria with evidence of mitochondrial degeneration. These findings are more prominent in the R92Q-Myc-92% line (compare Figure 5, e with f). In addition, frequent apoptotic nuclei can be seen in the higher-expressing line (data not shown). Taken together, these findings suggest that mutations in different functional domains within the cTnT molecule can lead to distinct phenotypes at the ultrastructural level and may form the basis for the varying phenotypes seen in cTnT-related FHC.
Ultrastructural abnormalities in cTnT-related FHC mice are allele specific. Representative electron micrographs from left ventricular tissue isolated from non-Tg (a), WT-Myc (b), truncation-Myc (c and d), and R92Q-Myc (e and f) mice at 5 weeks of age. Sections from non-Tg and WT-Myc both demonstrate ordered arrays of myofibrils and normal mitochondrial morphology and number. Sections from 2 independent truncation-Myc lines reveal frequent misregistration of Z bands, myofibrillar disarray, and degeneration. Mitochondria are variable in size and morphology is normal. In comparison, both the R92Q-Myc lines (e = 67%, f = 92%) demonstrate largely preserved sarcomeric structure; however, note the lipid deposition and increased numbers of small mitochondria with loss of well-defined membranes and cristae. ×15,000. Scale bar: 1 μm.
Expression of hypertrophic markers in R92Q-Myc mice. It is well established that the cardiac hypertrophic response is accompanied by a complex temporal array of changes in gene expression (35, 36). As an initial step in characterizing the progression of the ventricular pathology at the molecular level, a series of Northern blot analyses were performed on total ventricular RNA isolated from all 3 R92Q-Myc lines, WT-Myc, and non-Tg sibling mice at several time points: 1.5, 4.5, and 8 months (Figure 6, a and b). Each blot was sequentially hybridized with the well-characterized markers of hypertrophy, ANF and β-MyHC. ANF is induced at high levels at very early time points in the R92Q-Myc-92% line and remain high at the latest time point examined, 8 months of age (Figure 6b). Although ANF is also induced by 1.5 months in the 67% line, the initial degree of induction was smaller in magnitude and the levels seem to increase slowly over time, reaching a level equivalent to that seen in the 92% line by 8 months of age. Only low levels of ANF transcripts were found in RNA isolated from the 30% line, and this was not evident until 8 months of age. Similar results were seen with β-MyHC; however, there was a clear delay in the onset of marker induction between the 67% and 92% lines, with the 67% line demonstrating barely detectable β-MyHC mRNA by 4.5 months. In addition, unlike ANF, the induction of β-MyHC was clearly progressive over time in these 2 lines. No induction of β-MyHC was seen in the 30% line at any time point measured. No significant differences in β-MyHC or SERCA2 expression were found in any of the cTnT-Myc transgenic lines. No evidence for hypertrophic marker induction at any time point can be found in the WT-Myc or cTnT-Myc-truncation lines (see Figure 6b). Thus, it appears that as the degree of replacement of the normal cTnT protein with the R92Q-Myc form increases from 30% to 92%, both the magnitude and temporal expression of ANF and β-MyHC change in a transgene-specific pattern. This may well reflect a primary response of the ventricular myocyte to the degree of functional impairment caused by the presence of increasing amounts of R92Q-Myc protein within the cardiac sarcomere.
Induction of hypertrophic markers in R92Q-Myc mice. (a) Induction time-course Northern blot analysis of total ventricular RNA isolated from non-Tg (NT), WT-Myc (WT), and all 3 R92Q-Myc Tg lines. Age at time of RNA isolation is noted for each lane. The blot was serially hybridized with a radiolabeled β-MyHC oligonucleotide probe and ANF and GAPDH cDNA probes as described in Methods. (b) Northern blot analysis of total ventricular RNA isolated from non-Tg (NT), WT-Myc (WT), truncation-Myc (Tr), and all 3 R92Q-Myc Tg lines. A total of 10 μg of total RNA was loaded per lane. The blot was serially hybridized with α-MyHC and β-MyHC oligonucleotide probes, followed by ANF, SERCA2, cTnT, and GAPDH cDNA probes. Note that the cTnT probe detects both endogenous (as seen in NT lanes) and transgene transcripts.
Functional analysis of R92Q-Myc mice reveals hypercontractility and diastolic dysfunction. Patients with FHC demonstrate a wide range of cardiovascular physiological profiles. Symptoms consistent with diastolic dysfunction are commonly seen and have previously been at least partially attributed to the degree of ventricular hypertrophy (19). Patients also frequently demonstrate marked hypercontractile systolic function, and treatment with negative inotropic medications is a mainstay of clinical management (36). The cause of the observed hypercontractility, however, remains unclear. To gauge the functional effects of the R92Q-Myc protein on whole-heart hemodynamics, an isolated work-performing model was used (37). The data presented here derive from the R92Q-Myc-67% mice. We also attempted to analyze the R92Q-Myc-92% hearts, but the profound atrial enlargement prevented successful preparations. The R92Q-Myc-67% hearts exhibited significantly higher intrinsic heart rates than age-matched non-Tg siblings (∼425 vs. 370 beats per minute). Thus, to control for chronotropic differences in contractile function, both transgenic and non-Tg hearts were paced at 425 beats per minute in all subsequent experiments. Systolic (+dP/dT) and diastolic (–dP/dT) performance were assessed by increasing volume (venous return), thus varying cardiac minute workload from 250 to 600 mmHg × mL/min in a stepwise fashion. A summary of hemodynamic data is shown in Table 3. The R92Q-Myc-67% hearts produce maximal rates of pressure development (+dP/dT) that are significantly increased (+18%) relative to controls at similar workloads. This increase in systolic function is also reflected in a significant decrease (–30%) in the time required to reach peak intraventricular pressure (TPP). Careful examination of the relaxation indices –dP/dT, RT1/2 (time to 50% relaxation), and Tau (time constant of ventricular relaxation) reveals a clear impairment of diastolic function in R92Q-Myc hearts. The diastolic dysfunction is largely restricted to the early diastolic/late phase of relaxation (represented by the significant increase (+136% in Tau), whereas the initial "fast" phase of the diastolic pressure drop is unaffected (RT1/2). The net effect would be a prolongation of isovolumic relaxation with a higher potential for early activation. In patients with hypertrophic cardiomyopathy, prolongation of isovolumic relaxation is a relatively common finding that has largely been attributed to the presence of hypertrophy and nonuniformity (38). Another proposed mechanism is abnormal Ca2+ handling. Because the R92Q-Myc-67% mice do not demonstrate ventricular hypertrophy, we believe that the observed diastolic dysfunction is secondary to either Ca2+ hypersensitivity (due to the increased sarcomeric activation) or an alteration in Ca2+ homeostasis within the cardiac myocyte. Thus, the R92Q-Myc-67% mice exhibit 2 of the most common clinical findings in patients with FHC: hypercontractility and diastolic dysfunction.
Means ± SEM of measured cardiac parameters: Starling loading (100–600 mmHg × mL/min)
Isolated R92Q-Myc cardiac myocytes demonstrate impaired relaxation. To determine whether contractile function in the isolated working heart was reflected at the level of the cardiac myocyte, cellular contractility studies were performed on isolated cells from non-Tg, WT-Myc, and R92Q-Myc-67% mice. The extent of myocyte shortening, both in absolute and relative terms, tends to be smaller in R92Q-Myc myocytes (Table 4). During pacing, myocyte-shortening rate and velocity are both significantly slower in myocytes from R92Q-Myc mice. Relative to both non-Tg and WT-Myc cells, myocyte relaxation and overall contraction times are prolonged in R92Q-Myc cells (Table 4 and Figure 7). Taken at face value, these data are indicative of impaired myocyte contraction and relaxation. The latter observation at the single-cell level is consistent with the results of the isolated working heart data, whereas the former observation is not. However, mean resting sarcomere lengths in the R92Q-Myc myocytes were significantly shorter than in the WT-Myc myocytes. As mentioned earlier, this difference may have been reflective of a higher basal level of contractile element activation in the R92Q myocytes. The shorter sarcomere lengths in the R92Q-Myc cells would be expected to have a suppressive effect on myocyte shortening, because contractions would be elicited at less optimal sarcomere lengths and against a stronger passive restoring force (see Discussion). Finally, significant differences between non-Tg and WT-Myc are only observed in time to peak shortening and time to 50% relengthening. This illustrates the utility of including a WT-Myc control in this type of experiment.
Representative ventricular myocyte-shortening dynamics. Non-Tg (solid line), WT-Myc (dashed line), and R92Q-Myc (dotted line) are shown above. "Fractional length" (ordinate label) refers to cell shortening as a fraction of resting cell length. Myocyte-shortening dynamics for each cell type were reconstructed from the data presented in Table 1 (and mean times to 25%, 75%, and 90% relengthening; not reported in Table 1) by interpolation.
Isolated ventricular myocyte-shortening characteristics
In this study, we present evidence that the expression of a cTnT FHC allele, R92Q, in the mouse heart results in a complex cardiovascular phenotype that exhibits both similarities and differences relative to a previously described mouse model expressing a truncated FHC-related cTnT allele (17). Although these 2 models demonstrate some phenotypic overlap (particularly with regard to decreased left ventricular mass), they remain distinct at several levels, which we believe directly reflects the degree of functional impairment of the cTnT protein and may well provide insight into the molecular pathogenesis of this complex disorder.
Since the identification of the first disease-related allele in 1990, it has become clear that the broad range of clinical phenotypes is matched by a striking genetic heterogeneity. The clinical phenotypes vary both within and among the numerous disease alleles and may well reflect the varied structural and functional roles of the contractile proteins within the cardiac myocyte. It has been noted that the cTnT-related FHC alleles result in a particularly malignant clinical phenotype whereby approximately 50% of affected patients experience sudden cardiac death by the third decade of life (30).
Despite the absence of ventricular hypertrophy in the R92Q mice, the 2 higher-expressing lines (67% and 92%) demonstrate significant induction of both ANF and β-MyHC transcripts. Both the timing of onset and magnitude of the induction are distinct between all 3 lines. In comparison, the previously described Myc-truncation lines do not exhibit induction of hypertrophic markers at identical time points. While the underlying mechanisms are unknown, the timing of the onset of hypertrophic marker expression in the R92Q-Myc lines does appear to correlate with both the extent and severity of the later pathological findings (e.g., fibrosis), thus providing a qualitative marker for the progression of pathology in this model system. None of these markers is induced in the TnT-truncation mice, where myocellular disarray is common but fibrosis is rare, suggesting that expression of these genes may be related to fibrosis.
The ultrastructural findings in hypertrophic cardiomyopathy are quite varied and include decreased mitochondrial size, myofibrillar lysis, changes in Z-band morphology, and myofibrillar disorientation (34–39). No relationship between morphological changes and cardiac functional status has been identified (40). These studies, however, were performed before the availability of genotype analysis for FHC; thus, no information is currently available regarding allele- or gene-specific ultrastructural findings. Ultrastructural examination of cardiac tissues from 5-week-old R92Q-Myc mice reveals early cellular changes. The R92Q-Myc-67% myocytes demonstrate scattered areas of disorganization, lipid deposition, and mitochondrial degeneration. The findings in the higher-expressing R92Q-Myc-92% lines are largely similar yet more extensive, and evidence of myocyte apoptosis is also observed (data not shown). Of note, sarcomere structure is largely preserved. Although the mechanism underlying these findings is unknown, both lipid deposition and mitochondrial lysis are commonly seen in ischemic cardiac tissue (41, 42). One possibility is that the increased level of basal sarcomeric activation observed in R92Q-Myc myocytes has led to a chronic increase in oxygen demand (MVO2) that, over time, results in the ultrastructural changes we have observed. Experiments to test this hypothesis are in progress.
The R92Q-Myc ultrastructural findings are in stark contrast to those seen in the Myc-truncation myocytes, and these differences may well represent the effects of the primary cTnT mutation on the cardiac sarcomere. The incorporation of less than 6% of total cTnT as the truncated form led to focal myofibrillar lysis and misregistration of Z bands. Mitochondrial structure was normal, and no lipid deposition was observed in the Myc-truncation lines. The cTnT-truncation molecule has effectively lost a significant portion of the 3′ TnI-TnC-TM binding site and would likely result in a troponin complex that exhibits an altered Ca2+ sensitivity. Incorporation of this "on" or "off" protein may lead to local stresses within the sarcomere and result in structural breakdown. In comparison, the R92Q-Myc mutation represents a single–amino acid substitution in the Myc-truncation binding site of cTnT. As we have shown, this mutation does not affect the ability of the transgenic protein to incorporate into the myofibril. Recent cTnT exchange experiments using a permeabilized rabbit cardiac muscle fiber system have shown that incorporation of a human R92Q cTnT molecule leads to an increase in Ca2+ sensitivity without altering the maximally activated fiber tension (14). Thus, the R92Q-Myc mutation may act as a "change-in-function" allele rather than the "poison polypeptide" truncation mutation, and this difference may be reflected in the ultrastructural findings.
A major advantage of using a transgenic approach to study the functional effects of point mutations on contractile proteins is the ability to directly correlate in vitro findings to whole-heart contractility. Studies performed on adult cardiac myocytes isolated from WT-Myc, R92Q-Myc, and non-Tg hearts suggest that the presence of the R92Q point mutation results in a higher basal level of sarcomeric activation. In the present experiments, inhibiting the actomyosin cross-bridges by incubating the cells in BDM elicited a markedly greater increase in cell length in the R92Q-Myc myocytes compared with either control group. The mechanism that underlies this increase in contractile element activation is currently unknown. One possible explanation is that the substitution of glutamine for the positively charged arginine at cTnT codon 92 alters the interaction between TM and the troponin complex, such that cross-bridge formation occurs at a lower [Ca2+]. Although the verification of this "partial activation" model awaits the availability of the high-resolution crystal structure of cTnT, the end effect would be an apparent increase in Ca2+ sensitivity. This hypothesis is supported by the findings of Morimoto et al. (14), wherein the exchange of a human R92Q-cTnT molecule into permeabilized rabbit cardiac muscle fibers resulted in a clear decrease in the free [Ca2+] required for tension generation.
The subsequent effects on cardiac contractility caused by this elevation in the basal level of sarcomeric activation would be expected to be complex. As a first step in addressing this issue, we examined the shortening characteristics of isolated adult cardiac myocytes from R92Q-Myc, WT-Myc, and non-Tg animals. The expectation would be that the increase in contractile protein activation would lead to a concomitant increase in contractility due to heightened cross-bridge formation at submaximal Ca2+. The R92Q-Myc myocytes, however, exhibited a decrease in both maximal shortening velocity (–dS/dTmax) and maximal shortening rate constant, which is suggestive of a decrease in overall contractility. These data, however, must be interpreted in the context of the observed shorter myocyte and sarcomere lengths at baseline in R92Q-Myc myocytes. The shorter basal sarcomere lengths in the R92Q-Myc cells would be expected to have suppressive effect on myocyte shortening for 2 reasons. First, contraction in R92Q-Myc myocytes was initiated at shorter (less optimal) sarcomere lengths in contrast to WT-Myc cells. Second, the extent of myocyte shortening is determined by the interaction between an active contractile process that generates force and promotes shortening and a passive restoring force that resists shortening. Because intrinsic myocyte length is not different between experimental groups when the actin cross-bridge interaction is inhibited by BDM, it is likely that contraction of R92Q-Myc cells is initiated against a greater restoring force, which would, in turn, directly oppose active myocyte shortening. Thus, the slower measured contractile indices are not necessarily reflective of the active contraction status of the R92Q-Myc myocytes. In contrast, the increased basal level of contractile element activation found in R92Q-Myc myocytes would be expected to have a depressive effect on relaxation in that the threshold for inhibition of cross-bridge formation would be increased. Our data support this hypothesis in that both the maximal relengthening velocity (+dS/dTmax) and the maximal relengthening rate constant are significantly decreased in R92Q-Myc myocytes compared with both the WT-Myc and non-Tg controls.
Our isolated cardiac myocyte data represent the effects of a primary alteration in sarcomeric function on single-cell contractility. These findings are clearly reflected in the subsequent physiological effects seen at the whole-heart level. Hearts isolated from R92Q-Myc-67% animals and subjected to a stepwise increase in cardiac workload exhibit both hypercontractility and impaired relaxation compared with non-Tg littermates. In contrast, hearts isolated from Myc-truncation mice demonstrated impairment of both systolic and diastolic function. This again illustrates an important distinction between the 2 models that we believe reflects on the nature of the primary mutation. In many cases of humans with FHC, the severity of the symptoms correlates to the degree of left ventricular hypertrophy, with a decrease in compliance leading to increased filling pressures and worsening of symptoms over time (19). It has long been noted, however, that in some cases the clinical symptoms are clearly out of proportion to the degree of hypertrophy. This "cellular diastolic dysfunction" is thought to be due to changes in Ca2+ handling at the level of the cardiac myocyte, and is supported by our findings in that both cTnT-Myc animal models exhibit diastolic dysfunction in the absence of ventricular hypertrophy. Although another common noninvasive clinical finding in FHC patients is cardiac hypercontractility, the underlying cause remains unclear. We believe that the observed hypercontractility in the R92Q-Myc-67% mice is a direct result of the basal increase in contractile element activation observed in the isolated cell studies. Thus, the characterization of the R92Q-Myc transgenic mice results in findings that are internally consistent from the level of the point mutation in a single sarcomeric protein to the resultant physiology at the whole-heart level.
One of the most basic questions regarding the pathogenesis of cTnT-related FHC in patients is the actual mechanism of the observed sudden death. It is again important to note that patients with cTnT-related FHC tend to exhibit mild or no ventricular hypertrophy, yet experience a high frequency of sudden death at an early age. This suggests that the primary effects of the point mutation act at the level of the cardiac myocyte. Indeed, the issue of a cellular phenotype for one of the β-MyHC–related FHC mouse models was recently addressed in an interesting report by Spindler et al. (43), wherein they documented changes in cardiac energetics (specifically decreased [PCr]) in hearts isolated from αMHC403/+ mice. This report represents the first opportunity to examine 2 different disease alleles within the same gene. The striking differences exhibited by the mice expressing the 2 mutations have made it possible to conclude that many of the phenotypes can exist in the absence of others. For example, disarray can exist without fibrosis, and diastolic dysfunction can occur in the absence of hypertrophy. In addition, the analyses of isolated cells and the intact heart have provided new insight into the mechanisms of pathogenesis of FHC.
This work was supported by grants from the National Institutes of Health (HL-50560 to L.A. Leinwand; HL-060546 to J. Robbins; and HL-40306 to R.L. Moore). The authors thank Yvonne Kress for electron micrographs, Ed Yellin for discussions about diastolic dysfunction (both of Albert Einstein College of Medicine, Bronx, New York, USA), Murali Chandra and R. John Solaro for discussions about TnT (University of Illinois, Chicago, Illinois, USA), Kurt Haubold for confocal microscopy, and Jill Jones for help in manuscript and figure preparation (both of University of Colorado, Boulder, Colorado, USA).
Towbin, J. The role of cytoskeletal proteins in cardiomyopathies. Curr Opin Cell Biol 1998. 10:131-139.
View this article via: PubMed CrossRef Google Scholar
Watkins, H, Seidman, JG, Seidman, CE. Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum Mol Genet 1995. 4:1721-1727.
View this article via: PubMed Google Scholar
Sweeney, HL, Straceski, AJ, Leinwand, LA, Faust, L. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J Biol Chem 1994. 269:1603-1605.
Sata, M, Ikebe, M. Functional analysis of the mutations in the human cardiac β-myosin that are responsible for familial hypertrophic cardiomyopathy. J Clin Invest 1996. 98:2866-2873.
View this article via: JCI PubMed Google Scholar
Roopnarine, O, Leinwand, LA. Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy. Biophys J 1998. 75:3023-3030.
Vikstrom, KL, Factor, SM, Leinwand, LA. Mice expressing mutant myosin are a model for hypertrophic cardiomyopathy. Mol Med 1996. 2:556-567.
Geisterfer-Lowrance, AAT, et al. A mouse model of familial hypertrophic cardiomyopathy. Science 1996. 272:731-734.
Tobacman, LS. Thin filament-mediated regulation of cardiac contraction. Annu Rev Physiol 1996. 58:447-481.
Perry, SV. Troponin T: genetics, properties and function. J Muscle Res Cell Motil 1998. 19:575-602.
Thierfelder, L, et al. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994. 77:701-712.
Watkins, H, Seidman, CE, Seidman, JG, Feng, HS, Sweeney, HL. Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. J Clin Invest 1997. 98:2456-2461.
Marian, AJ, Zhao, G, Seta, Y, Roberts, R, Yu, Q-T. Expression of a mutant (Arg92Gln) human troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility. Circ Res 1997. 81:76-85.
Lin, D, Bobkova, A, Homsher, E, Tobacman, LS. Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy. J Clin Invest 1996. 97:2842-2848.
Morimoto, S, Yanaga, F, Minakami, R, Ohtsuki, I. Ca2+-sensitizing effects of the mutations at Ile-79 and Arg92 of troponin T in hypertrophic cardiomyopathy. Am J Physiol 1998. 275:C200-C207.
Cuda, G, Fananapazir, L, Epstein, ND, Sellers, JR. The in vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutation in hypertrophic cardiomyopathy. J Muscle Res Cell Motil 1997. 18:275-283.
Sweeney, HL, Feng, HS, Yang, Z, Watkins, H. Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. Proc Natl Acad Sci USA 1998. 95:14406-14410.
Tardiff, JC, et al. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Invest 1998. 101:2800-2811.
Oberst, L, et al. Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice. J Clin Invest 1998. 102:1498-1505.
Maron, BJ, Bonow, RO, Cannon, RO, Leon, MB, Epstein, SE. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy. Part I. N Engl J Med 1987. 316:780-789.
Lawson, JW. Hypertrophic cardiomyopathy: current views on etiology, pathophysiology, and management. Am J Med Sci 1998. 294:191-210.
Evan, GI, Lewis, GK, Ramsey, G, Bishop, JM. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol 1985. 5:3610-3616.
Tantravahi, J, Alvira, M, Falck-Pedersen, E. Characterization of the mouse βmaj globin transcription termination region: a spacing sequence is required between the poly(A) signal sequence and multiple downstream termination elements. Mol Cell Biol 1993. 13:578-587.
Hogan, B., Constantini, F., and Lacy, E. 1986. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor Press. Cold Spring Harbor, NY. 1–487.
Chomczynski, P, Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987. 162:156-169.
Wolska, BM, Solaro, RJ. Method for isolation of adult mouse cardiac myocytes for studies of contraction and microfluorimetry. Am J Physiol 1997. 271:H1250-H1255.
Stuaffer, BL, Palmer, BM, Hazel, A, Cheung, JY, Moore, RL. Hypertension alters rapid cooling contractures in single rat cardiocytes. Am J Physiol 1997. 271:C1000-C1006.
Williams, JL, Hathaway, CA, Kloster, KL, Layne, BH. Low power, type II errors and other statistical problems in recent cardiovascular research. Am J Physiol 1997. 273:H487-H493.
Watkins, H, et al. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995. 332:1058-1064.
Forissier, JF, et al. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation 1996. 94:3069-3073.
Moolman, JC, et al. Sudden death due to troponin T mutations. J Am Coll Cardiol 1997. 29:549-555.
Gulick, J, et al. Transgenic remodeling of the regulatory myosin light chains in the mammalian heart. Circ Res 1997. 80:655-664.
Gwathmey, JK, Hajjar, RJ, Solaro, RJ. Contractile deactivation and uncoupling of cross-bridges: effects of 2,3-butanedionemonoxime on mammalian myocardium. Circ Res 1991. 69:1280-1292.
Davies, MJ, McKenna, W. Hypertrophic cardiomyopathy: pathology and pathogenesis. Histopathology 1995. 26:493-500.
Maron, BJ, Ferrans, VJ, Roberts, WC. Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy. Am J Pathol 1975. 79:387-434.
Vikstrom, KL, Bohlmeyer, T, Factor, SM, Leinwand, LA. Hypertrophy, pathology and molecular markers of cardiac pathogenesis. Circ Res 1998. 82:773-778.
Schaub, MC, Hefti, MA, Harder, BA, Eppenberger, HM. Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J Mol Med 1997. 75:901-920.
Grupp, IL, Subramaniam, A, Hewett, TE, Robbins, J, Grupp, G. Comparison of normal, hypodynamic, and hyperdynamic mouse hearts using isolated work-performing heart preparations. Am J Physiol 1993. 265:H1401-H1410.
Betocchi, S, Hess, OM, Losi, MA, Nonogi, H, Krayenbuehl, HP. Regional left ventricular dynamics in hypertrophic cardiomyopathy. Circulation 1993. 88:2206-2214.
Tashiro, A, Masuda, T, Segawa, I. Morphometric comparison of mitochondria and myofibrils of cardiomyocytes between hypertrophic and dilated cardiomyopathies. Virchows Arch A Pathol Anat Histopathol 1990. 416:473-478.
Baandrup, U, Florio, RA, Roters, F, Olsen, EG. Electron microscopic investigation of endomyocardial biopsy samples in hypertrophy and cardiomyopathy. A semiquantitative study in 48 patients. Circulation 1981. 63:1289-1298.
Greve, G, Rotevatn, S, Svendby, K, Grong, K. Early morphologic changes in cat heart muscle cells after acute coronary artery occlusion. Am J Pathol 1990. 136:273-283.
Miyazima, K, et al. Ischemic myocardial mitochondrial function and ultrastructural change: influence of regional myocardial blood flow. Jpn Circ J 1991. 55:714-720.
Spindler, M, et al. Diastolic dysfunction and altered energetics in the αMHC403/+ mouse model of familial hypertrophic cardiomyopathy. J Clin Invest 1998. 101:1775-1783.
Version 1 (August 15, 1999): No description


text:
Календаско () —  коммуна в Италии, располагается в регионе Эмилия-Романья, подчиняется административному центру Пьяченца.

Население составляет 2310 человек, плотность населения составляет 62 чел./км². Занимает площадь 37 км². Почтовый индекс — 29010. Телефонный код — 0523.

Покровителем населённого пункта считается святой Конрад из Пьяченцы. Праздник ежегодно празднуется 19 февраля.

Ссылки

redpajama_set_name: RedPajamaWikipedia